About OliX Pharmaceuticals

OliX is a clinical stage biotechnology company, based on their own proprietary RNA interference (RNAi) technology regulating the expression of disease-causing genes.

Company Highlights
Year Founded

2010

icon-altEmployees

43

Location (HQ)

KOR

Since Last Funding

3 years 9 months

Monthly Website Visitors

11.0K

icon-altTotal Investment Amt

$38M

Last Funding Round

Post Ipo Equity

icon-altMoM Headcount Growth

-8.49%

icon-altYoY Headcount Growth

-12.22%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Medical

Pharmaceutical

Pharmaceutical Manufacturing

Pharmaceuticals